Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yue Chen, Hongliang Jin, Xiaoran Tang, Li Li, Xiuzhu Geng, Yuanmei Zhu, Huihui Chong & Yuxian He. (2022) Cell membrane-anchored anti-HIV single-chain antibodies and bifunctional inhibitors targeting the gp41 fusion protein: new strategies for HIV gene therapy. Emerging Microbes & Infections 11:1, pages 30-49.
Read now
Read now
Valentin Le Douce, Amina Ait-Amar, Faezeh Forouzan far, Faiza Fahmi, Jose Quiel, Hala El Mekdad, Fadoua Daouad, Céline Marban, Olivier Rohr & Christian Schwartz. (2016) Improving combination antiretroviral therapy by targeting HIV-1 gene transcription. Expert Opinion on Therapeutic Targets 20:11, pages 1311-1324.
Read now
Read now
Articles from other publishers (11)
Sizhu Duan, Xin Yu, Chu Wang, Lina Meng, Yanxin Gai, Yan Zhou, Tiejun Gu, Bin Yu, Jiaxin Wu & Xianghui Yu. (2022) Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction. Journal of Virology 96:17.
Crossref
Crossref
Mouraya Hussein, Ben Berkhout & Elena Herrera-Carrillo. 2022. Biotechnologies for Gene Therapy. Biotechnologies for Gene Therapy
85
125
.
Qiaoqiao Xiao, Shuliang Chen, Qiankun Wang, Zhepeng Liu, Shuai Liu, Huan Deng, Wei Hou, Dongcheng Wu, Yong Xiong, Jiafu Li & Deyin Guo. (2019) CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4+ T cells and hematopoietic stem/progenitor cells promotes HIV-1 resistance and CD4+ T cell enrichment in humanized mice. Retrovirology 16:1.
Crossref
Crossref
Xiaoran Tang, Hongliang Jin, Yue Chen, Li Li, Yuanmei Zhu, Huihui Chong & Yuxian He. (2019) A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus. Journal of Virology 93:22.
Crossref
Crossref
Desheng Kong, Yan Wang, Ping Ji, Wei Li, Tianlei Ying, Jinghe Huang, Chen Wang, Yanling Wu, Yanping Wang, Weizao Chen, Yanling Hao, Kunxue Hong, Yiming Shao, Dimiter S. Dimitrov, Shibo Jiang & Liying Ma. (2018) A defucosylated bispecific multivalent molecule exhibits broad HIV-1-neutralizing activity and enhanced antibody-dependent cellular cytotoxicity against reactivated HIV-1 latently infected cells. AIDS 32:13, pages 1749-1761.
Crossref
Crossref
Bo Li, Wanrong Guo, Fan Zhang, Meiyan Liu, Shang Wang, Zhonghua Liu, Shuanglin Xiang & Youlin Zeng. (2017) Synthesis and evaluation of L-arabinose-based cationic glycolipids as effective vectors for pDNA and siRNA in vitro. PLOS ONE 12:7, pages e0180276.
Crossref
Crossref
Maximilian Müller, Tafadzwa Mlambo & Claudio Mussolino. 2017. Safety and Efficacy of Gene-Based Therapeutics for Inherited Disorders. Safety and Efficacy of Gene-Based Therapeutics for Inherited Disorders
137
157
.
Himanshu GargAnjali Joshi. (2016) Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification. Human Gene Therapy 27:5, pages 400-415.
Crossref
Crossref
Ravi BirlaRavi Birla. 2016. Tissue Engineering for the Heart. Tissue Engineering for the Heart
1
30
.
Chang Li, Xinmeng Guan, Tao Du, Wei Jin, Biao Wu, Yalan Liu, Ping Wang, Bodan Hu, George E. Griffin, Robin J. Shattock & Qinxue Hu. (2015) Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9. Journal of General Virology 96:8, pages 2381-2393.
Crossref
Crossref
Hong-tao Shang, Ji-wei Ding, Shu-ying Yu, Tao Wu, Qiu-li Zhang & Fu-jun Liang. (2015) Progress and challenges in the use of latent HIV-1 reactivating agents. Acta Pharmacologica Sinica 36:8, pages 908-916.
Crossref
Crossref